
FDA approves noninvasive blood test for colorectal cancer screening
The FDA has approved Freenome's SimpleScreen CRC, a blood-based screening test for adults 45+ at average risk, offering a noninvasive option to detect colorectal cancer with results in weeks; in a large study, it detected about 80% of cancers and correctly ruled out cancer or advanced precancer in about 90% of those without disease, signaling potential to boost screening rates alongside existing tests, though costs and Stage 1 sensitivity remain under discussion.












